BioSeek Our vision is to harness the predictive power of integrative cell systems biology to improve human health. BioSeek, an Asterand company, is improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. Our BioMAP ® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative biological activity profiles for each potential drug. As a result, our technology drives the selection and development of new drug candidates. We leverage our BioMAP ® Systems technology in collaborations to enhance the productivity of our pharmaceutical partners' pipelines to identify promising compounds for therapeutic development. Asterand plc acquired BioSeek on February 18, 2010. Asterand is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. BioSeek's BioMAP ® platform and primary human cell based assays are highly complementary to the human tissue-based products and services offered by Asterand. Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, Asterand plc is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From our offices in Royston (United Kingdom), San Francisco, California and Detroit, Michigan we have more than 90 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety. Asterand's mission is to provide human tissues and services to accelerate the identification and validation of drug targets and enhance the selection of drug candidates with an increased likelihood of clinical success.